Steve Sosnick, Interactive Brokers’ chief strategist, discusses why there have been some recent rallies and sell-offs in the market.
Will market lows be tested over the next few sessions?
,
Photo Credit: PapaPiper via Flickr Creative Commons
AUTHOR
Interactive Brokers Traders Insight
297 postsYou may also like
The Fed Chairman hasn’t been sleeping – he tells his psychiatrist why.
The US has taken the brunt of the crushing selloff
In June, the American Society of Clinical Oncology (ASCO) hosted its 60th Annual Meeting, drawing over 40,000 attendees from around the globe. This year’s event largely focused on validating revolutionary treatment categories like Chimeric antigen receptor (CAR) T-cell therapies and antibody drug conjugates (ADCs). Given proven clinical benefits across a wider array of cancer types, we expect these novel treatment categories to become increasingly important in the fight against cancer and the growth profiles of select companies in the healthcare space.
Volatility in many markets is up, but not dramatically so.